During the third quarter of fiscal year 2016, Narwhal Capital Management increased its stake in Nashville, Tenn.-based AmSurg by 2.6 percent, according to The Cerbat-Gem.
Here are three notes:
1. The firm had a nearly $1.1 million stake in AmSurg at the end of Q3.
2. Citigroup rated AmSurg shares a "buy" rating on Sept. 26, 2016.
3. Citigroup set a $79 price target on AmSurg shares.